Hong Sheng Xu

Director Ejecutivo en Shapuaisi Qiangshen Pharma Co., Ltd. .

42 años

Health Technology

Perfil

Hong Sheng Xu is currently the General Manager & Director at Shapuaisi Qiangshen Pharma Co., Ltd.
Previously, he held the position of Chairman-Supervisory Board at Zhejiang Shapuaisi Pharmaceutical Co. Ltd.

Cargos activos de Hong Sheng Xu

Empresas	Cargo	Inicio
Shapuaisi Qiangshen Pharma Co., Ltd. Shapuaisi Qiangshen Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Jilin Yueshi Tianbo Pharmaceutical Co., Ltd., Shapuaisi Qiangshen Pharma Co., Ltd. manufactures tablets, hard capsules, and granules. The company is based in Dongfeng County, China. The Chinese company was founded in 2014. The CEO is Hong Sheng Xu. Shapuaisi Qiangshen Pharma Co. was acquired by Jilin Yueshi Tianbo Pharmaceutical Co., Ltd. from Zhejiang Shapuaisi Pharmaceutical Co. Ltd. on January 26, 2022 for $12.50 million.	Director Ejecutivo	-

Todos los cargos activos de Hong Sheng Xu

Antiguos cargos conocidos de Hong Sheng Xu.

Empresas	Cargo	Fin
ZHEJIANG SHAPUAISI PHARMACEUTICAL CO.,LTD.	Presidente	-

Ver el detalle de la experiencia de Hong Sheng Xu.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Hong Sheng Xu.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
ZHEJIANG SHAPUAISI PHARMACEUTICAL CO.,LTD.	Health Technology

Empresas privadas	1
Shapuaisi Qiangshen Pharma Co., Ltd. Shapuaisi Qiangshen Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Jilin Yueshi Tianbo Pharmaceutical Co., Ltd., Shapuaisi Qiangshen Pharma Co., Ltd. manufactures tablets, hard capsules, and granules. The company is based in Dongfeng County, China. The Chinese company was founded in 2014. The CEO is Hong Sheng Xu. Shapuaisi Qiangshen Pharma Co. was acquired by Jilin Yueshi Tianbo Pharmaceutical Co., Ltd. from Zhejiang Shapuaisi Pharmaceutical Co. Ltd. on January 26, 2022 for $12.50 million.	Health Technology